HSBC Holdings’s Allergan Inc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q1
Sell
-542,932
Closed -$115M 2202
2014
Q4
$115M Buy
542,932
+219,406
+68% +$43.6M 0.24% 86
2014
Q3
$57.7M Buy
323,526
+58,064
+22% +$9.64M 0.12% 170
2014
Q2
$45.1M Buy
265,462
+54,451
+26% +$8.48M 0.1% 208
2014
Q1
$26M Sell
211,011
-138,783
-40% -$16.9M 0.06% 323
2013
Q4
$38.8M Buy
349,794
+27,792
+9% +$2.65M 0.1% 220
2013
Q3
$29.1M Sell
322,002
-99,870
-24% -$8.97M 0.08% 285
2013
Q2
$35.5M Buy
+421,872
New +$43.8M 0.11% 199

Other funds holding AGN

HSBC Holdings's AGN Position: Q1 2015 in Review

HSBC Holdings sold out of Allergan Inc (AGN) in Q1 2015, closing a stake of 542,932 shares — an estimated $115M sold.

HSBC Holdings first reported a position in AGN in Q2 2013 and held it in 7 quarters. The position peaked at $115M in Q4 2014. 5 funds tracked by Wall St. Rank hold AGN as of Q1 2015.

  • HSBC Holdings reported no remaining Allergan Inc position as of Q1 2015 after selling out during the quarter.
  • HSBC Holdings sold 542,932 Allergan Inc shares in Q1 2015, an estimated $115M.
  • HSBC Holdings first reported a position in Allergan Inc in Q2 2013 and held it in 7 quarters.
  • HSBC Holdings's Allergan Inc position peaked at $115M in Q4 2014.
  • 5 funds tracked by Wall St. Rank held Allergan Inc as of Q1 2015.

Based on HSBC Holdings's 13F filing for Q1 2015, filed 14 May 2015.